Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.76 |
| ▸ | MAOB | P27338 | 5/20 | 0.70 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.61 |
| ▸ | TNKS | O95271 | 1/20 | 0.61 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.61 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Chloro-Cinnamic Acid SCHEMBL79591 | 1.00 | CYP1A2 (0.76) | CYP1A2CYP2C9MAOBNPSR1HDAC3 | |
| 3-Chloro-Cinnamic Acid SCHEMBL22396853 | 1.00 | CYP1A2 (0.76) | CYP1A2CYP2C9MAOBNPSR1HDAC3 | |
| 3-Chloro-Cinnamic Acid SCHEMBL11469853 | 0.98 | CYP1A2 (0.73) | CYP1A2CYP2C9MAOBNPSR1HDAC3 | |
| 3-Chloro-Cinnamic Acid SCHEMBL9632314 | 0.98 | CYP1A2 (0.73) | CYP1A2CYP2C9MAOBNPSR1HDAC3 | |
| 3-Chloro-Cinnamic Acid SCHEMBL7753489 | 0.87 | MAOB (0.60) | CYP1A2CYP2C9MAOBNPSR1HDAC3 | |
| SCHEMBL11844491 | 0.87 | CYP1A2 (0.64) | CYP1A2CYP2C9MAOBNPSR1MAOA | |
| SCHEMBL11851984 | 0.87 | CYP1A2 (0.64) | CYP1A2CYP2C9MAOBNPSR1MAOA | |
| SCHEMBL31553466 | 0.86 | CYP1A2 (1.00) | CYP1A2CYP2C9MAOBNPSR1MAOA | |
| SCHEMBL22596713 | 0.86 | CYP1A2 (0.79) | CYP1A2CYP2C9MAOBNPSR1MAOA | |
| SCHEMBL5598564 | 0.86 | CYP1A2 (1.00) | CYP1A2CYP2C9MAOBNPSR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| CN-117430128-B | Preparation method and application of copper-doped ZSM-5 zeolite molecular sieve containing mesoporous structure | 常州大学 | 2025-04-25 | — | — | CN | claimed |
| CN-117430125-B | Preparation method and application of manganese doped mesoporous structure-containing acidic Beta zeolite molecular sieve | 常州大学 | 2025-03-21 | — | — | CN | claimed |
| CN-118955813-A | Low-temperature early-strength water reducer and preparation method thereof | 北京工业大学 | 2024-11-15 | — | — | CN | claimed |
| CN-115594675-B | Beta-carbalin-cinnamic acid skeleton derivative and preparation method and application thereof | 西安医学院 | 2024-01-30 | — | — | CN | claimed |
| CN-117430125-A | Preparation method and application of manganese doped mesoporous structure-containing acidic Beta zeolite molecular sieve | 常州大学 | 2024-01-23 | — | — | CN | claimed |
| CN-117430128-A | Preparation method and application of copper-doped ZSM-5 zeolite molecular sieve containing mesoporous structure | 常州大学 | 2024-01-23 | — | — | CN | claimed |
| CN-116949024-A | Phenylalanine ammonia lyase mutant and application thereof in synthesis of (S) -2-chloro-phenylalanine | 江南大学 | 2023-10-27 | — | — | CN | claimed |
| CN-115594675-A | Beta-carbalin-cinnamic acid skeleton derivative and preparation method and application thereof | 西安医学院（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-115260176-A | Pyrazole amide derivative containing oxazole group and preparation method and application thereof | 安徽农业大学 | 2022-11-01 | — | — | CN | claimed |
| EP-1526584-A2 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | Samsung Electronics Co., Ltd (KR) | 2005-04-27 | — | — | EP | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
| EP-1282680-A1 | COMPOSITIONS COMPRISING CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 2003-02-12 | — | — | EP | claimed |
| US-6503413-B2 | Polyalkylene polysiloxane, buffering agent, aqueous carrier | THE PROCTER & GAMBLE COMPANY | 2003-01-07 | — | — | US | claimed |
| EP-1255806-A1 | STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-13 | — | — | EP | claimed |
| US-20020011584-A1 | Stable, aqueous compositions for treating surfaces, especially fabrics | THE PROCTOR & GAMBLE COMPANY | 2002-01-31 | — | — | US | claimed |
| US-20020010154-A1 | Compositions comprising cyclodextrin | THE PROCTER & GAMBLE COMPANY | 2002-01-24 | — | — | US | claimed |
| WO-2001088076-A1 | COMPOSITIONS COMPRISING CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-22 | — | — | WO | claimed |
| WO-2001060961-A1 | STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| EP-0327021-B1 | COATING COMPOSITIONS FOR PREVENTING ADHESION OF AQUATIC ORGANISMS | KANSAI PAINT CO. LTD. (JP) | 1993-06-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010154-A1 | Compositions comprising cyclodextrin | FFAR4, FRG1, FGB | CYP1A2 2261/4885CYP2C9 269/4885MAOB 3237/4885 |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | ADRB3, ADRB1, CHRM3 | CYP1A2 592/4885CYP2C9 1672/4885MAOB 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.